참고문헌
- McCullough PA, Choi JP, Feghali GA, Schussler JM, Stoler RM, Vallabahn RC, et al. Contrast-Induced Acute Kidney Injury. J Am Coll Cardiol 2016;68:1465-73. https://doi.org/10.1016/j.jacc.2016.05.099
- Wichmann JL, Katzberg RW, Litwin SE, Zwerner PL, De Cecco CN, Vogl TJ, et al. Contrast-Induced Nephropathy. Circulation 2015;132:1931-6. https://doi.org/10.1161/CIRCULATIONAHA.115.014672
- Hinson JS, Ehmann MR, Fine DM, Fishman EK, Toerper MF, Rothman RE, et al. Risk of Acute Kidney Injury After Intravenous Contrast Media Administration. Ann Emerg Med 2017;69:577-86.e4. https://doi.org/10.1016/j.annemergmed.2016.11.021
- Hsu TF, Huang MK, Yu SH, Yen DH, Kao WF, Chen YC, et al. N-acetylcysteine for the prevention of contrastinduced nephropathy in the emergency department. Intern Med 2012;51:2709-14. https://doi.org/10.2169/internalmedicine.51.7894
- Subramaniam RM, Suarez-Cuervo C, Wilson RF, Turban S, Zhang A, Sherrod C, et al. Effectiveness of Prevention Strategies for Contrast-Induced Nephropathy: A Systematic Review and Meta-analysis. Ann Intern Med 2016;164:406-16. https://doi.org/10.7326/M15-1456
- Kocher KE, Meurer WJ, Fazel R, Scott PA, Krumholz HM, Nallamothu BK. National trends in use of computed tomography in the emergency department. Ann Emerg Med 2011;58:452-62.e3. https://doi.org/10.1016/j.annemergmed.2011.05.020
- Toprak O. Risk markers for contrast-induced nephropathy. Am J Med Sci 2007;334:283-90. https://doi.org/10.1097/MAJ.0b013e318068ddf9
- ACR.org. American College of Radiology. ACR Manual on Contrast Media. 2017. Available from: https://www.acr.org/Quality-Safety/Resources/Contrast-Manual [cited 14 June 2017].
- Barrett BJ, Parfrey PS. Clinical practice. Preventing nephropathy induced by contrast medium. N Engl J Med 2006;354:379-86. https://doi.org/10.1056/NEJMcp050801
- Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol 2004;183:1673-89. https://doi.org/10.2214/ajr.183.6.01831673
- Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast- agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4. https://doi.org/10.1056/NEJM200007203430304
- Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO Clinical Practice Guideline for Acute Kidney Injury. Kidney Int Suppl 2012;2:1-138. https://doi.org/10.1038/kisup.2012.1
- Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation 2011;124:e574-651. https://doi.org/10.1161/CIR.0b013e31823ba622
- Traub SJ, Mitchell AM, Jones AE, Tang A, O'Connor J, Nelson T, et al. N-acetylcysteine plus intravenous fluids versus intravenous fluids alone to prevent contrast-induced nephropathy in emergency computed tomography. Ann Emerg Med 2013;62:511-20. https://doi.org/10.1016/j.annemergmed.2013.04.012
- Poletti PA, Saudan P, Platon A, Mermillod B, Sautter AM, Vermeulen B, et al. IV N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity. AJR Am J Roentgenol 2007;189:687-92. https://doi.org/10.2214/AJR.07.2356
- Fishbane S, Durham JH, Marzo K, Rudnick M. N-acetylcysteine in the prevention of radiocontrast-induced nephropathy. J Am Soc Nephrol 2004;15:251-60. https://doi.org/10.1097/01.ASN.0000107562.68920.92
- Shalansky SJ, Vu T, Pate GE, Levin A, Humphries KH, Webb JG. N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best? Pharmacotherapy 2005;25:1095-103. https://doi.org/10.1592/phco.2005.25.8.1095
- DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R. N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 1997;272:F292-8.
- Marenzi G, Assanelli E, Marana I, Lauri G, Campodonico J, Grazi M, et al. N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. N Engl J Med 2006;354:2773-82. https://doi.org/10.1056/NEJMoa054209
- Dittrich R, Akdeniz S, Kloska SP, Fischer T, Ritter MA, Seidensticker P, et al. Low rate of contrast-induced Nephropathy after CT perfusion and CT angiography in acute stroke patients. J Neurol 2007;254:1491-7. https://doi.org/10.1007/s00415-007-0528-5
- Wu MY, Hsiang HF, Wong CS, Yao MS, Li YW, Hsiang CY, et al. The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: a metaanalysis of randomized controlled trials. Int Urol Nephrol 2013;45:1309-18. https://doi.org/10.1007/s11255-012-0363-1
- K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.